BENDAMUSTINE S.K. 25 MG

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

BENDAMUSTINE AS HYDROCHLORIDE MONOHYDRATE

Disponible desde:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

Código ATC:

L01AA09

formulario farmacéutico:

POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Composición:

BENDAMUSTINE AS HYDROCHLORIDE MONOHYDRATE 25 MG/VIAL

Vía de administración:

I.V

tipo de receta:

Required

Fabricado por:

AZAD PHARMA AG, SWITZERLAND

Área terapéutica:

BENDAMUSTINE

indicaciones terapéuticas:

First-line of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotheraphy is not appropiate. Indolent non-Hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.

Fecha de autorización:

2019-12-09